Multiple sclerosis (MS) is a common cause of neurological disability in young adults.
1 Most patients experience bouts of inflammatory demyelination (relapsing-remitting MS) followed years later by treatment-resistant disease progression and brain atrophy.
2 A higher MS risk in individuals with low vitamin D intake
3 or low circulating 25-hydroxyvitamin D (25[OH]D),
4-7 as well as an inverse correlation between vitamin D status and MS activity, have been reported
8-11 and suggest that vitamin D is related to the disease process that leads to and perpetuates MS. However, previous clinical studies were conducted among patients with variable disease duration and could not determine whether low vitamin D is a consequence of MS activity
12 or whether vitamin D levels early in the disease course contribute to predict long-term progression and disability. Because the prevalence of vitamin D insufficiency (25[OH]D<50 nmol/L [20 ng/mL]) is high,
13 supplementation could potentially benefit a large proportion of patients with MS.